Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Effexor Dosage: The 150 mg Threshold and What Changes

Clinically reviewed by Daniel Montville, MD

Reviewed October 21, 2026 · Last updated September 25, 2026

Key Takeaways

  • For depression, Effexor XR usually starts at 75 mg a day, sometimes after 4 to 7 days at 37.5 mg, and can rise in steps of up to 75 mg to a maximum of 225 mg for outpatients.
  • At 75 mg, venlafaxine acted mainly as a serotonin reuptake inhibitor in a study of depressed patients. A norepinephrine effect appeared at 225 mg and 375 mg, and brain imaging detected norepinephrine transporter blockade at 150 to 300 mg.
  • The 150 mg threshold is a useful shorthand, not a switch. Imaging found no clear increase in norepinephrine blockade above 150 mg, and a healthy-volunteer study found none at 150 or 300 mg.
  • Higher doses bring more blood pressure risk. Mean blood pressure rose in trials only at doses above 75 mg, and a pooled analysis found clinically significant diastolic increases mainly above 300 mg a day.

If your prescriber has talked about moving your Effexor from 75 mg to 150 mg, you may have heard that 150 is where it “becomes an SNRI.” That shorthand is partly right. The part it leaves out matters for your blood pressure, your side effects, and what you should expect from the increase.

Your brain uses serotonin and norepinephrine as two separate messaging systems, each recycled by its own transporter. The Effexor XR prescribing information describes venlafaxine and its active metabolite as potent inhibitors of both serotonin and norepinephrine reuptake, but lab studies have long shown it binds the serotonin transporter more strongly. Which system a given dose reaches, and with what precision, is the real question behind the 150 mg number.

The standard dosing is well defined. For depression, the label recommends starting at 75 mg a day and raising the dose by up to 75 mg at a time, no more often than every 4 days, to a maximum of 225 mg for outpatients. Its effectiveness rests on placebo-controlled trials in both outpatients and inpatients. The results are real, and the science is well established.

But a dose number alone doesn’t tell you which system you’re treating, and at Siggy we think you should know what a dose change is meant to do before you make it. Dual-action dosing, meaning the dose range where venlafaxine blocks norepinephrine reuptake as well as serotonin, has been measured directly with blood pressure challenge tests and brain imaging. This guide walks through what those studies found and how it plays out in your own dosing, based on the measured pharmacology.

What This Page Covers

How Effexor Dosing Works

Effexor XR (venlafaxine extended-release) is FDA-approved for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder in adults. For depression, the label’s usual starting dose is 75 mg once a day with food. Some people start at 37.5 mg for 4 to 7 days to adjust first.

If 75 mg isn’t enough, the dose can rise in steps of up to 75 mg, at intervals of at least 4 days, to 225 mg a day. In the trials that established its effectiveness, increases happened no more often than every 2 weeks. The immediate-release tablet has been studied at higher doses: in a 4-week inpatient trial of severe, melancholic depression, doses ranged from 150 to 375 mg, and completers averaged 350 mg a day.

The drug clears quickly. Venlafaxine’s half-life is about 5 hours, and its active metabolite, O-desmethylvenlafaxine, is about 11 hours, so both reach steady state within 3 days. That metabolite is sold on its own as Pristiq, which our guide to Pristiq dosage covers.

Doses are lower for some people. The label recommends reducing the daily dose by 25% to 50% in mild or moderate kidney impairment and by 50% in mild to moderate liver impairment. For social anxiety disorder, the recommended dose is 75 mg, and the label found no evidence that higher doses add benefit.

What Is the Effexor 150 mg Threshold?

The idea is simple. At low doses, venlafaxine behaves mostly like an SSRI because it binds the serotonin transporter more readily. As the dose climbs, enough drug builds up to block the norepinephrine transporter too, and 150 mg is often cited as the point where that second effect kicks in.

This matters for how you feel and for your safety. Norepinephrine is involved in alertness, and it also helps regulate blood vessels, which is why higher doses can raise blood pressure. For more on how the two drug classes compare, see our guide to SNRIs versus SSRIs.

What the Studies Show About Norepinephrine

The serotonin side is established early. In a brain imaging study of five antidepressants, the minimum therapeutic dose of each drug, including extended-release venlafaxine, occupied roughly 80% of serotonin transporters, and occupancy plateaued at higher doses.

The norepinephrine side shows up later. A dose comparison in 44 depressed patients used a tyramine challenge, which measures how much a drug blunts a blood pressure spike driven by norepinephrine. At 75 mg, venlafaxine didn’t change the response, while patients forced up to 225 mg and 375 mg showed a significant effect. Both groups had the same drop in blood serotonin, and depression scores didn’t differ between them over 4 weeks.

Imaging fills in the middle. A PET study of 12 patients on venlafaxine XR found norepinephrine transporter occupancy of 8% to 61%, rising with dose. Patients taking 150 to 300 mg had significantly more blockade than untreated controls, but occupancy didn’t clearly increase beyond 150 mg.

One study points the other way. A study in healthy volunteers using the same tyramine test found no norepinephrine effect at either 150 or 300 mg after 5 days of dosing, even though a comparison drug clearly showed one. The authors couldn’t explain the gap, and it suggests that the threshold may differ between people and settings.

Put together, 150 mg is roughly where norepinephrine blockade becomes measurable in patients, not a switch that flips for everyone. Every study here is small, and one of the imaging studies included co-authors from the drug’s manufacturer.

Does a Higher Effexor Dose Work Better?

Sometimes, but the average gain shrinks as the dose climbs. A 2019 dose-response meta-analysis of fixed-dose trials found venlafaxine’s effect increased up to about 75 to 150 mg and then rose more modestly, with dropouts lowest in the lower part of the licensed range.

The label tells a similar story for anxiety. For generalized anxiety disorder, it says a dose-response relationship wasn’t clearly established between 75 and 225 mg, and for social anxiety, doses of 150 to 225 mg weren’t more effective than 75 mg in a 6-month study.

So the label’s advice that people who don’t respond to 75 mg may benefit from an increase still holds, but the average added benefit is modest, while blood pressure and withdrawal risks keep climbing with dose.

Effexor Doses at a Glance

The table below summarizes each common dose, drawing on the Effexor XR label and the studies above.

Dose Serotonin Effect Norepinephrine Effect Key Note
75 mg About 80% transporter occupancy No tyramine effect Usual target dose
150 mg Plateaued Measurable on PET Near top of dose-response curve
225 mg Plateaued Tyramine effect present Outpatient XR maximum
375 mg Plateaued Tyramine effect present Studied in inpatients, immediate-release

Blood pressure is the clearest dose-related risk. In the label’s placebo-controlled trials, mean blood pressure barely changed at doses of 75 mg or less but rose at doses above 75 mg, and sustained high diastolic pressure occurred in 3% of people treated for depression at 75 to 375 mg. The label advises checking blood pressure before starting and regularly during treatment.

The risk grows steeply at the top of the range. A pooled analysis of 3,744 patients found venlafaxine’s effect on diastolic blood pressure was highly dose-dependent and clinically significant mainly above 300 mg a day. It also found venlafaxine didn’t worsen blood pressure control in people who already had high blood pressure.

Other side effects appear at every dose. Across the label’s trials, nausea affected 30% of people on Effexor XR versus 11.8% on placebo, and insomnia, dizziness, sleepiness, dry mouth, and sweating were also more common. Sexual side effects, including abnormal ejaculation in 9.9% of men, were reported as well.

Stopping gets harder at higher doses. The label reports that discontinuation symptoms such as dizziness, nausea, anxiety, and electric-shock sensations became more frequent with higher doses and longer treatment. In its trials, tapering meant lowering the dose by 75 mg a week, and some people need several months to stop.

How Prescribers Decide Whether to Go Past 75 mg

A dose increase often follows a few weeks of partial improvement rather than a set schedule. Your prescriber is weighing how much your mood, sleep, energy, and anxiety have shifted, what side effects you’re having, and what your blood pressure is doing.

If you’re considering an increase, a few questions are worth asking:

  • How much of my improvement so far should I expect to add at the higher dose?
  • Should my blood pressure be checked before and after the change?
  • Which side effects should I watch for in the first week or two?
  • If the increase doesn’t help, what’s the plan for coming back down?

Like all antidepressants, Effexor XR carries a boxed warning about suicidal thoughts and behaviors in children, teens, and young adults, and the label advises close monitoring when doses change. If you have thoughts of harming yourself, call 911 or the 988 Suicide and Crisis Lifeline right away.

How Siggy Thinks About Dose Changes

Dose changes are where good information matters most, and where it’s most often missing. “No one checks in to see if it’s actually working” is something we hear from patients, and a dose increase without follow-up is exactly how side effects and blood pressure changes slip by.

Effexor is one of the medications a Siggy prescriber can consider, and whether it fits your plan is a decision a licensed prescriber makes after reviewing your intake. Siggy is designed to follow how your mood, sleep, and side effects change over time, so a real doctor sees the pattern before and after any adjustment.

The 150 mg threshold is a reasonable way to think about Effexor, as long as you treat it as a gradient. Serotonin effects are close to maxed out at 75 mg, norepinephrine effects become measurable somewhere around 150 mg, and blood pressure and withdrawal risks keep climbing after that. The tradeoff is that a higher dose may help a partial responder but asks more of your body. For a closer look at how prescribers weigh dose changes in general, see our guide to how doctors decide on Lexapro dosage. Siggy’s free, anonymous intake takes no name, email, or login, and you get a consult summary and a downloadable report you can share with any clinician.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

What is the normal starting dose of Effexor?

For depression, Effexor XR usually starts at 75 mg once a day with food. Some people start at 37.5 mg for 4 to 7 days first. Doses can rise by up to 75 mg at intervals of at least 4 days, to a maximum of 225 mg a day for outpatients.

Does Effexor become an SNRI at 150 mg?

Roughly, but not at a sharp cutoff. In depressed patients, 75 mg showed no norepinephrine effect while 225 mg and 375 mg did, and brain imaging detected norepinephrine transporter blockade at 150 to 300 mg. A healthy-volunteer study found no effect at 150 or 300 mg, so individual response likely varies.

Is 150 mg of Effexor more effective than 75 mg?

Sometimes, but the gain is modest on average. A dose-response meta-analysis found venlafaxine's effect rose up to about 75 to 150 mg and then increased more slowly. The label's target dose is 75 mg, and increases are usually made when response is incomplete.

What is the maximum dose of Effexor?

For Effexor XR in outpatients, the label maximum is 225 mg a day. The immediate-release form has been studied up to 375 mg a day in severely depressed inpatients, where the average dose among completers was 350 mg.

Does a higher Effexor dose raise blood pressure?

Yes, the effect is dose-related. In the label's trials, mean blood pressure rose at doses above 75 mg but barely changed at 75 mg or less, and a pooled analysis of 3,744 patients found clinically significant diastolic increases mainly above 300 mg a day. The label recommends checking blood pressure before and during treatment.

Why are Effexor withdrawal symptoms worse at higher doses?

The label reports that discontinuation symptoms became more frequent with higher doses and longer treatment. Venlafaxine also has a short half-life of about 5 hours, and its active metabolite about 11 hours, so levels fall quickly. Tapering with your prescriber is recommended.

Sources

  1. DailyMed. Effexor XR (venlafaxine hydrochloride) extended-release capsules Prescribing Information. Viatris Specialty LLC. U.S. National Library of Medicine. dailymed.nlm.nih.gov
  2. Meyer JH, Wilson AA, Sagrati S, et al. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. American Journal of Psychiatry. 2004;161(5):826-835. doi:10.1176/appi.ajp.161.5.826
  3. Debonnel G, Saint-André E, Hébert C, et al. Differential physiological effects of a low dose and high doses of venlafaxine in major depression. International Journal of Neuropsychopharmacology. 2007;10(1):51-61. doi:10.1017/S1461145705006413
  4. Arakawa R, Stenkrona P, Takano A, et al. Venlafaxine ER blocks the norepinephrine transporter in the brain of patients with major depressive disorder: a PET study using [18F]FMeNER-D2. International Journal of Neuropsychopharmacology. 2019;22(4):278-285. doi:10.1093/ijnp/pyz003
  5. Blier P, Saint-André E, Hébert C, et al. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. International Journal of Neuropsychopharmacology. 2007;10(1):41-50. doi:10.1017/S1461145705006395
  6. Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry. 2019;6(7):601-609. doi:10.1016/S2215-0366(19)30217-2
  7. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. Journal of Clinical Psychiatry. 1998;59(10):502-508. doi:10.4088/jcp.v59n1002